These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23684658)

  • 1. Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies.
    Abdelbary GA; Tadros MI
    Int J Pharm; 2013 Aug; 452(1-2):300-10. PubMed ID: 23684658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies.
    Nour SA; Abdelmalak NS; Naguib MJ; Rashed HM; Ibrahim AB
    Drug Deliv; 2016 Nov; 23(9):3681-3695. PubMed ID: 27648847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies.
    Seju U; Kumar A; Sawant KK
    Acta Biomater; 2011 Dec; 7(12):4169-76. PubMed ID: 21839863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring micellar-based polymeric systems for effective nose-to-brain drug delivery as potential neurotherapeutics.
    Pokharkar V; Suryawanshi S; Dhapte-Pawar V
    Drug Deliv Transl Res; 2020 Aug; 10(4):1019-1031. PubMed ID: 31858442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain targeting efficiency of intranasal clozapine-loaded mixed micelles following radio labeling with Technetium-99m.
    Sayed S; Elsharkawy FM; Amin MM; Shamsel-Din HA; Ibrahim AB
    Drug Deliv; 2021 Dec; 28(1):1524-1538. PubMed ID: 34266360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel self-assembled nano-tubular mixed micelles of Pluronics P123, Pluronic F127 and phosphatidylcholine for oral delivery of nimodipine: In vitro characterization, ex vivo transport and in vivo pharmacokinetic studies.
    Basalious EB; Shamma RN
    Int J Pharm; 2015 Sep; 493(1-2):347-56. PubMed ID: 26241752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid based colloidal poloxamer-nanocubic vesicles for brain targeting via the nasal route.
    Salama HA; Mahmoud AA; Kamel AO; Abdel Hady M; Awad GA
    Colloids Surf B Biointerfaces; 2012 Dec; 100():146-54. PubMed ID: 22766291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles.
    Baltzley S; Mohammad A; Malkawi AH; Al-Ghananeem AM
    AAPS PharmSciTech; 2014 Dec; 15(6):1598-602. PubMed ID: 25142821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study.
    Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y
    Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery.
    Rashed HM; Shamma RN; Basalious EB
    Drug Deliv; 2016 Nov; 24(1):181-187. PubMed ID: 28156162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
    Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
    Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.
    Wei Z; Hao J; Yuan S; Li Y; Juan W; Sha X; Fang X
    Int J Pharm; 2009 Jul; 376(1-2):176-85. PubMed ID: 19409463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B; Khunt D; Misra M; Padh H
    Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.
    Ahmed TA; El-Say KM; Ahmed OA; Aljaeid BM
    Int J Nanomedicine; 2019; 14():5555-5567. PubMed ID: 31413562
    [No Abstract]   [Full Text] [Related]  

  • 16. Tri-block co-polymer nanocarriers for enhancement of oral delivery of felodipine: preparation, in vitro characterization and ex vivo permeation.
    Sayed S; Habib BA; Elsayed GM
    J Liposome Res; 2018 Sep; 28(3):182-192. PubMed ID: 28480807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier.
    Liu JS; Wang JH; Zhou J; Tang XH; Xu L; Shen T; Wu XY; Hong Z
    Int J Nanomedicine; 2014; 9():3923-35. PubMed ID: 25152622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and
    Khallaf RA; Aboud HM; Sayed OM
    J Liposome Res; 2020 Jun; 30(2):163-173. PubMed ID: 31039651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of Polymeric Micelles as a Lucrative Platform for Efficient Brain Deposition of Olanzapine as an Antischizophrenic Drug via Intranasal Delivery.
    Abo El-Enin HA; Ahmed MF; Naguib IA; El-Far SW; Ghoneim MM; Alsalahat I; Abdel-Bar HM
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of brain targeting efficiency of intranasal microemulsion containing olanzapine: pharmacodynamic and pharmacokinetic consideration.
    Patel RB; Patel MR; Bhatt KK; Patel BG; Gaikwad RV
    Drug Deliv; 2016; 23(1):307-15. PubMed ID: 24845478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.